Social media influencers have been making bold claims that GLP-1 medications — the same drugs used for weight loss and ...
MedPage Today on MSN
FDA Approves First Non-Antipsychotic Drug for Alzheimer's Agitation
Oral NMDA receptor antagonist gets an expanded indication ...
U.S.-based drugmaker Eli Lilly on Wednesday launched its Alzheimer's drug Lormalzi, also known as Donanemab, in India.
A new paper, published in Science Translational Medicine, investigated whether levetiracetam, an anti-seizure medication, could form the basis for innovative drug treatments for Alzheimer’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results